Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Metabolism01:19

Regulation of Metabolism

9.2K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
9.2K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urban-rural disparities in child linear growth: a decomposition analysis of digital, physical, and socioeconomic environments in seven least-developed countries.

Journal of global health·2026
Same author

Urbanization compound pathways of global lung cancer incidence risk under proximal and distal interactions.

iScience·2026
Same author

Community-level COVID-19 vaccination promotion capacity and its association with vaccination dose per capita in China: an entropy-weighted TOPSIS and multilevel analysis.

BMC public health·2026
Same author

Long-term assessment of nutrient-induced eutrophication in Xiamen Bay: Implications for integrated watershed-coast management.

Marine environmental research·2026
Same author

Ultrafast cascaded energy transfer triggers highly luminescent Te<sup>4+</sup>-doped Cs<sub>2</sub>ZrCl<sub>6</sub> perovskites.

Optics letters·2026
Same author

xCT/SLC7A11-mTOR axis promotes vascular remodeling in pulmonary arterial hypertension.

The international journal of biochemistry & cell biology·2026

Related Experiment Video

Updated: May 29, 2025

Measuring Mitochondrial Function of Na&#239;ve and Effector CD8 T Cells
06:07

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

191

NOD1: a metabolic modulator.

Ruobing Tang1, Chunguang Xie1,2,3, Xiyu Zhang1,2,3

  • 1Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

Frontiers in Endocrinology
|February 5, 2025
PubMed
Summary
This summary is machine-generated.

Nucleotide-binding oligomerization domain 1 (NOD1) acts as a metabolic regulator in multiple tissues. Activated NOD1 is implicated in the pathology of metabolic diseases, highlighting its broad physiological roles.

Keywords:
NOD1endocrineimmunityinflammationmetabolism

More Related Videos

Analysis of Human Natural Killer Cell Metabolism
09:03

Analysis of Human Natural Killer Cell Metabolism

Published on: June 22, 2020

6.8K
Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide
07:34

Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide

Published on: May 12, 2023

966

Related Experiment Videos

Last Updated: May 29, 2025

Measuring Mitochondrial Function of Na&#239;ve and Effector CD8 T Cells
06:07

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells

Published on: March 28, 2025

191
Analysis of Human Natural Killer Cell Metabolism
09:03

Analysis of Human Natural Killer Cell Metabolism

Published on: June 22, 2020

6.8K
Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide
07:34

Quantitative Determination of De Novo Fatty Acid Synthesis in Brown Adipose Tissue Using Deuterium Oxide

Published on: May 12, 2023

966

Area of Science:

  • Immunology
  • Metabolic Science
  • Cell Biology

Background:

  • Nucleotide-binding oligomerization domain 1 (NOD1) is an intracellular pattern recognition receptor.
  • NOD1 detects danger signals, initiating inflammatory and host defense responses.
  • NOD1 also functions as a metabolic mediator across various tissues.

Purpose of the Study:

  • To comprehensively review the impact of NOD1 on tissue-specific metabolism.
  • To summarize the diverse mechanisms by which NOD1 influences metabolic processes.
  • To highlight the association between activated NOD1 and metabolic disease pathology.

Main Methods:

  • Literature review of studies investigating NOD1's role in metabolism.
  • Analysis of research on NOD1's influence on adipose tissue, liver, cardiovascular system, pancreatic β cells, adrenal glands, and bones.
  • Synthesis of findings on NOD1's involvement in metabolic disease pathogenesis.

Main Results:

  • NOD1 significantly impacts the metabolism of key tissues such as adipose tissue and liver.
  • Diverse mechanisms are employed by NOD1 to regulate metabolic pathways.
  • Evidence links activated NOD1 to the pathological mechanisms of several metabolic diseases.

Conclusions:

  • NOD1 plays a critical role in maintaining tissue-specific metabolic homeostasis.
  • Dysregulation of NOD1 contributes to the development of metabolic disorders.
  • Further research into NOD1's metabolic functions may reveal therapeutic targets for metabolic diseases.